|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 728.30 GBX | +0.23% |
|
-3.01% | -19.69% |
| 07-17 | WINNERS & LOSERS: Vega ups Vodafone stake; GSK drug trial disappoints | AN |
| 07-13 | SBG Securities Cuts Mondi's PT, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 9.06 | +7.11% | 12 | ||||||
| 55.04 | +25.91% | 14 | ||||||
| 246.4 | +5.34% | 10 | ||||||
| 42.73 | +12.71% | 11 | ||||||
| 16.48 | +10.63% | 13 | ||||||
| 62 | +10.09% | 9 | ||||||
| 38.59 | +41.19% | 4 | ||||||
| 7.986 | +17.64% | 9 | ||||||
| 33.01 | +9.13% | 18 | ||||||
| 11.8 | +7.37% | 11 | ||||||
| 34.4 | +18.62% | 10 | ||||||
| 1,656.67 | +11.94% | 6 | ||||||
| 4.067 | -0.81% | 3 | ||||||
| 94 | +19.14% | 3 | ||||||
| 80.83 | +14.74% | 6 | ||||||
| 2.96 | +8.27% | 5 | ||||||
| 3.774 | +17.15% | 4 | ||||||
| Average | 141.16 | +13.89% | 9 | ||||||
| Weighted average by Cap. | 110.49 | +14.88% | 11 |
- Stock Market
- Stocks
- MNDI Stock
- Sector Mondi plc
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
